Multiple Sclerosis Journal

Multiple Sclerosis Journal is a peer-reviewed international journal focusing on all aspects of multiple sclerosis, neuromyelitis optica, and other related autoimmune diseases of the central nervous system.《多发性硬化杂志》（Multiple Sclerosis Journal）是一份同行评审国际期刊，聚焦多发性硬化、视神经脊髓炎以及其他相关中枢神经系统自身免疫性疾病的所有方面。

Scope

The journal's stated aim is to publish research on all aspects of multiple sclerosis and related central nervous system autoimmune diseases, with its official scope covering:刊物官方宗旨为发表多发性硬化及相关中枢神经系统自身免疫性疾病各方面的研究，官方声明的征稿范围包括：

• Epidemiology and genetics: research on the genetics and epigenetics of multiple sclerosis and related disorders, epidemiological studies of disease incidence and prevalence, and the environmental and lifestyle factors that contribute to disease risk.流行病学与遗传学： 关于多发性硬化及相关疾病遗传与表观遗传、疾病发病率与患病率流行病学研究以及促成疾病风险的环境与生活方式因素的研究。
• Clinical and neuroimaging: studies on the clinical manifestations, diagnosis, and progression of disease, including biomarkers, neuroimaging techniques such as magnetic resonance imaging, and clinical outcome measures.临床与神经影像学： 关于疾病临床表现、诊断与进展的研究，涵盖生物标志物、磁共振成像等神经影像学技术以及临床结局指标等。
• Immunology and pathogenesis: work on the immunological mechanisms underlying multiple sclerosis and related disorders, including the role of T cells, B cells, antibodies, and the blood-brain barrier in disease pathogenesis.免疫学与发病机制： 关于多发性硬化及相关疾病免疫学机制的研究，涵盖 T 细胞、B 细胞、抗体以及血脑屏障在疾病发病机制中的作用等。
• Therapeutics and rehabilitation: research on disease-modifying therapies, symptomatic treatments, rehabilitation, neuroplasticity, neuroprotection, and the systematic management of patients with multiple sclerosis and related disorders.治疗与康复： 关于疾病修饰疗法、对症治疗、康复、神经可塑性、神经保护以及多发性硬化及相关疾病患者系统管理的研究。
• Article types: original research articles, reviews, short communications, and guidelines, with an emphasis on work that advances understanding of disease mechanisms or improves clinical outcomes.栏目设置： 接受原创研究论文、综述、短讯与指南，强调推进疾病机制理解或改善临床结局的工作。

History

• Founding: the journal was founded in 1995 by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) to provide a dedicated forum for multiple sclerosis research. Ingrid Allen of Queen's University Belfast served as its first editor-in-chief.创刊： 该刊 1995 年由欧洲多发性硬化治疗与研究委员会（ECTRIMS）创刊，为多发性硬化研究提供专门论坛；贝尔法斯特女王大学的英格丽德·艾伦担任首任主编。
• Publication frequency: the journal began as a quarterly publication in 1995. The frequency increased to eight issues in 1996, stabilised at seven to eight issues per year between 1997 and 2006, and rose to nine issues per year from 2007 onward.出版频率： 该刊 1995 年创刊时为季刊，1996 年增至每年 8 期，1997 至 2006 年间稳定在每年 7 至 8 期，2007 年起增至每年 9 期。
• ECTRIMS affiliation: throughout its history the journal has been closely affiliated with ECTRIMS, serving as the official journal of the committee and reflecting its mission to advance research and treatment in multiple sclerosis.ECTRIMS 隶属： 在整个历史中该刊一直与 ECTRIMS 紧密联系，作为该委员会官方期刊并体现其推进多发性硬化研究与治疗的使命。
• Sage publication: the journal is published by SAGE Publications and has grown to become a leading international venue for research on multiple sclerosis and related disorders.SAGE 出版： 该刊由 SAGE 出版公司出版，已发展为多发性硬化及相关疾病研究的国际顶尖平台。

Editors

The journal is led by an editor-in-chief supported by associate editors and an international editorial board:该刊由主编领导，副编辑与国际编委会协助工作：

• Editor-in-chief: Jaume Sastre-Garriga, a neurologist and researcher whose work focuses on multiple sclerosis, neuroimmunology, and the clinical and imaging assessment of demyelinating diseases.主编： 豪梅·萨斯特雷—加里加（Jaume Sastre-Garriga），神经病学家与研究者，研究方向为多发性硬化、神经免疫学以及脱髓鞘疾病的临床与影像学评估。
• Associate editors: associate editors cover the major areas within the journal's scope, from epidemiology and genetics to clinical, imaging, and therapeutic research, and support the handling of manuscripts across these areas.副编辑团队： 副编辑覆盖刊物范围内从流行病学与遗传学到临床、影像学与治疗研究的主要领域，协助处理这些领域的稿件。
• Review model: manuscripts undergo single-blind peer review by external experts, with final decisions made by the editor-in-chief based on scientific rigor, novelty, and relevance to multiple sclerosis and related disorders.评审模式： 稿件由外部专家进行单盲同行评审，主编基于科学严谨性、新颖性与对多发性硬化及相关疾病的相关性做出最终决定。